MedVi vs IVIM Health: Semaglutide, Price and Support Compared

Quick verdict: MedVi vs IVIM Health

MedVi and IVIM Health both offer clinician-prescribed compounded GLP-1 options, but they target different priorities: MedVi emphasizes a low promotional starting price and 24/7 certified support, while IVIM Health emphasizes third-party ratings, a structured GLP-1 ID protocol, and both semaglutide and tirzepatide options. Early verdict: choose MedVi for the lowest first-month promo and a no-clinic workflow, choose IVIM Health for a dual 4.9-star reputation and a protocol-driven program.

Explore MedVi starting at $179

Overview: what each provider claims

MedVi markets clinically dosed compounded semaglutide starting at $179 for the first month with fast, free shipping, a simple online intake, no clinic visits, and 24/7 certified medical support. IVIM Health offers compounded semaglutide and tirzepatide with a free month membership using code GIFT75, a no-obligation free consultation, and reports a 4.9-star rating on Google and Trustpilot.

Distinctive differences at a glance

Comparison table

Price and promotions compared

MedVi advertises a winter promotional first-month price of $179 including fast, free shipping, but notes the ongoing standalone month rises to $299 and a three-month plan is available at $649. IVIM Health promotes a free month membership with code GIFT75, a no-obligation free consultation, and publishes ongoing pricing around $174/month. Both operate on a direct-pay model and state that compounded medications are cash-pay.

Claim IVIM’s GIFT75 free month

Medication choices and clinical approach

MedVi focuses on compounded semaglutide with clinician review and promises clinically dosed compounded formulations. IVIM Health offers both compounded semaglutide and compounded tirzepatide, and highlights a proprietary GLP-1 ID protocol intended to personalize titration and optimization. IVIM presents protocol outcomes as a proprietary claim and notes these are not independent head-to-head trial results.

See MedVi’s semaglutide program

Trust signals, outcomes claims, and regulatory cautions

IVIM Health emphasizes unusually strong third-party validation with 4.9-star ratings on both Google and Trustpilot. IVIM also references internal and published observational studies supporting its protocol, while noting these are not randomized controlled head-to-head trials. MedVi cites self-reported patient data and notes results vary; it also states compounded medications are produced in regulated facilities but are not FDA-approved. Both providers include regulatory notes that compounded drugs are not FDA-approved and may carry different risks than FDA-approved branded products.

Prescribing, access, and support differences

MedVi’s selling points are a fully online intake, a claim of 24/7 certified medical support, and no required clinic visits. IVIM provides a free consultation for new patients and a clinician-guided GLP-1 ID protocol with ongoing dose adjustments. Both require clinician review and prescriptions are at the clinician’s discretion.

Start IVIM’s free consultation

Final comparison and how to choose

MedVi vs IVIM Health comes down to priorities: MedVi is centered on a low promotional entry price, no clinic visits, and round-the-clock certified support. IVIM Health is centered on clinician-guided optimization, broader medication options including tirzepatide, a published protocol claim about accelerated outcomes, and strong third-party ratings.

Choose MedVi if you want the lowest advertised first-month promotional price, a simple online process with no clinic visits, and 24/7 certified medical support. Choose IVIM Health if you value verified third-party ratings, a proprietary GLP-1 ID protocol, and the option of compounded tirzepatide as well as semaglutide.

Primary keyword: MedVi vs IVIM Health